XML 28 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Interest expense $ (235.1) $ (219.1) $ (274.9)
Operating income 1,364.2 1,312.4 996.8
Net sales 10,205.9 9,437.2 8,505.7
Reimbursement Revenue 235.5 204.6 174.4
Revenues 10,441.4 9,641.8 8,680.1
Cost of sales 6,741.9 6,256.7 5,602.4
Cost of Reimbursable Expense 235.5 204.6 174.4
Cost of Revenue 6,977.4 6,461.3 5,776.8
Gross profit 3,464.0 3,180.5 2,903.3
Selling, general and administrative expenses 1,812.4 1,630.2 1,628.1
Amortization of intangibles and other assets 216.5 179.5 164.5
Restructuring and other special charges 70.9 58.4 113.9
Equity method income, net 11.3 7.9 10.0
Investment income 2.1 1.7 1.9
Other, net (7.6) 2.6 (7.8)
Earnings before income taxes 1,134.9 1,105.5 726.0
Net earnings 1,274.0 733.2 438.7
Less: Net earnings attributable to the noncontrolling interest 5.8 1.1 1.1
Net earnings attributable to Laboratory Corporation of America Holdings 1,268.2 732.1 437.6
Income Tax Expense (Benefit) $ (139.1) $ 372.3 $ 287.3